Infections in inflammatory Bowel Disease

被引:0
作者
Zeissig, Sebastian [1 ]
Schmelz, Renate [2 ]
机构
[1] Univ Klinikums Carl Gustav Carus Dresden, Med Klin 1, Dresden, Germany
[2] Univ Klinikum Carl Gustav Carus Dresden, Med Klin 1, Gastroenterol Ambulanz, Dresden, Germany
关键词
Infektion; Clostridium difficile; CMV; chronisch-entzundliche Darmerkrankungen; Morbus Crohn; infection; inflammatory bowel disease; Crohn's disease; NATIONWIDE DANISH COHORT; CAUSE-SPECIFIC MORTALITY; CROHNS-DISEASE; OPPORTUNISTIC INFECTIONS; CLOSTRIDIUM-DIFFICILE; ULCERATIVE-COLITIS; COMBINATION THERAPY; DIAGNOSIS; RISK; CYTOMEGALOVIRUS;
D O I
10.1055/s-0041-107951
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Zusammenfassung Infektionen tragen entscheidend zu Morbiditat und Mortalitat bei CED bei. Neben Malnutrition, Komorbiditaten und dem Patientenalter stellt insbesondere die immunsuppressive Therapie einen Risikofaktor fur opportunistische Infektionen dar. Wahrend das mit Kortikosteroiden, Thiopurinen und TNF-Antikorpern verbundene Infektionsrisiko in populationsbasierten Studien untersucht wurde, existieren bislang nur wenige Daten zum Infektionsrisiko unter darmselektiven Integrin-Antikorpern. Daruber hinaus existieren widerspruchliche Daten zum Infektionsrisiko unter einer immunsuppressiven Kombinationstherapie. Klinische Bedeutung kommt dem infektiologischen Screening vor medikamentoser Immunsuppression und der Abgrenzung des akuten CED-Schubes von intestinalen Infektionen zu. Abstract Infections significantly contribute to morbidity and mortality in inflammatory bowel diseases (IBD). Major risk factors for opportunistic infections in IBD include malnutrition, comorbidities, age and immunosuppression. While the risk of infection associated with corticosteroids, thiopurines, and TNF antibodies has been determined in large, population-based studies, less is known about the risk associated with antibodies targeting gut-selective integrins. Furthermore, controversial data exist regarding the risk of infection under combined immunosuppression. In clinical practice, screening for infectious diseases before medical immunosuppression and delineation of disease flares from infectious complications remains of critical importance.
引用
收藏
页码:196 / 200
页数:5
相关论文
共 50 条
[11]   Advances in the diagnosis and treatment of Clostridioides [Clostridium] difficile infections in inflammatory bowel disease [J].
Stallmach, Andreas ;
Reuken, Philipp A. ;
Teich, Niels .
ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2018, 56 (11) :1369-1377
[12]   Biologic-Induced Infections in Inflammatory Bowel Disease: The TNF-α Antagonists [J].
McConachie, Sean M. ;
Wilhelm, Sheila M. ;
Bhargava, Ashish ;
Kale-Pradhan, Pramodini B. .
ANNALS OF PHARMACOTHERAPY, 2018, 52 (06) :571-579
[13]   Risk factors for Clostridium difficile diarrhea in patients with inflammatory bowel disease [J].
Ramos-Martinez, Antonio ;
Ortiz-Balbuena, Jorge ;
Curto-Garcia, Isabel ;
Asensio-Vegas, Angel ;
Martinez-Ruiz, Rocio ;
Munez-Rubio, Elena ;
Cantero-Caballero, Mireia ;
Sanchez-Romero, Isabel ;
Gonzalez-Partida, Irene ;
Isabel Vera-Mendoza, Maria .
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2015, 107 (01) :4-9
[14]   Impact of Clostridium difficile on inflammatory bowel disease [J].
Ananthakrishnan, Ashwin N. ;
Binion, David G. .
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (05) :589-600
[15]   Risk of infections associated with biological treatment in inflammatory bowel disease [J].
Nynne Nyboe Andersen ;
Tine Jess .
World Journal of Gastroenterology, 2014, (43) :16014-16019
[16]   Fungal infections in patients with inflammatory bowel disease: A systematic review [J].
Stamatiades, George A. ;
Ioannou, Petros ;
Petrikkos, George ;
Tsioutis, Constantinos .
MYCOSES, 2018, 61 (06) :366-376
[17]   Cytomegalovirus in Inflammatory Bowel Disease: Pathogen or Innocent Bystander? [J].
Lawlor, Garrett ;
Moss, Alan C. .
INFLAMMATORY BOWEL DISEASES, 2010, 16 (09) :1620-1627
[18]   Clostridium difficile Infection in Patients with Inflammatory Bowel Disease [J].
Fu, Nancy ;
Wong, Titus .
CURRENT INFECTIOUS DISEASE REPORTS, 2016, 18 (06)
[19]   Testing for Clostridium difficile in Patients Newly Diagnosed with Inflammatory Bowel Disease in a Community Setting [J].
Krishnarao, Anita ;
de Leon, Lauren ;
Bright, Renee ;
Moniz, Heather ;
Law, Meaghan ;
Leleiko, Neal ;
Sands, Bruce E. ;
Merrick, Marjorie ;
Shapiro, Jason ;
Wallenstein, Sylvan ;
Giacalone, Julie ;
Shah, Samir A. .
INFLAMMATORY BOWEL DISEASES, 2015, 21 (03) :564-569
[20]   Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort [J].
Greuter, Thomas ;
Porchet, Frederic ;
Braga-Neto, Manuel B. ;
Rossel, Jean-Benoit ;
Biedermann, Luc ;
Schreiner, Philipp ;
Scharl, Michael ;
Schoepfer, Alain M. ;
Safroneeva, Ekaterina ;
Straumann, Alex ;
Rogler, Gerhard ;
Vavricka, Stephan R. .
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2020, 8 (10) :1196-1207